Industry update: the latest developments in the field of therapeutic delivery, March 2020.

Timmins, Peter

Timmins, Peter.

Timmins P; Department of Pharmacy, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.

Ther Deliv ; 11(8): 471-484, 2020 08.

Article in English | MEDLINE | ID: covidwho-2319894

Subject(s)

Betacoronavirus/metabolism; Coronavirus Infections/prevention & control; Drug Industry; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Vaccines, DNA; Antibodies, Monoclonal, Humanized/therapeutic use; Betacoronavirus/genetics; Betacoronavirus/immunology; COVID-19; Coronavirus Infections/therapy; Government Regulation; Lymphocytes/cytology; Lymphocytes/metabolism; Pneumonia, Viral/therapy; RNA Interference; RNA, Messenger/immunology; RNA, Messenger/metabolism; RNA, Small Interfering/therapeutic use; SARS-CoV-2; Vaccines, DNA/immunology; Vaccines, DNA/metabolism; gamma-Globulins/immunology; gamma-Globulins/therapeutic use

Keywords

COVID-19; cell therapies; clinical trials; drug delivery; gene therapy; mergers and acquisitions; oligonucleotides; product approvals; rare diseases; targeted therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Vaccines, DNA / Drug Industry / Pandemics / Betacoronavirus Topics: Vaccines Language: English Journal: Ther Deliv Year: 2020 Document Type: Article Affiliation country: Tde-2020-0056

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google